Research Article
The Effect of Early Treatment with Intravenous Magnesium Sulfate on the Incidence of Cardiac Comorbidities in Hospitalized Stroke Patients
Table 5
Outcomes for patients with CAEs in magnesium and placebo groups.
| | Total () | Patients with CAEs—magnesium group () | Patients with CAE—placebo group () | value |
| | Early outcomes | | | | | | Nurse GCS, median (IQR) | 14 (11-15) | 15 (11-15) | 14 (11-15) | 0.55 | | Nurse LAMS, median (IQR) | 5 (3-5) | 5 (3-5) | 5 (2-5) | 0.42 | | Nurse NIHSS, mean (SD) | 15.1 (9.2) | 15.9 (9.8) | 14.3 (8.6) | 0.27 | | 90-day outcomes | | | | | | mRS 90 d 0-1, (%) | 23 (14.6) | 10 (12.7) | 13 (16.5) | 0.65 | | mRS 90 d 0-2, (%) | 39 (24.7) | 20 (25.3) | 19 (24.1) | 1.0 | | mRS 90 d, mean (SD) | 4.1 (2.0) | 4.0 (2.0) | 4.2 (2.0) | 0.58 | | Mortality 90 d, (%) | 59 (37.1) | 28 (35.4) | 31 (38.8) | 0.73 |
|
|
